New Data Supporting
New Data Supporting Arno Therapeutics' HDAC Inhibitor AR-42 Published in The Journal of Urology
March 24, 2015 08:30 ET | Arno Therapeutics Inc.
FLEMINGTON, N.J., March 24, 2015 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company primarily focused on the development of oncology therapeutics,...
PotlatchDeltic logo LEFT_PMS 356 TM.png
Potlatch Schedules First Quarter 2015 Earnings Release and Conference Call for April 22nd
March 24, 2015 08:30 ET | PotlatchDeltic Corporation
SPOKANE, Wash., March 24, 2015 (GLOBE NEWSWIRE) -- Potlatch Corporation (Nasdaq:PCH) will release first quarter 2015 earnings results on Wednesday, April 22, 2015, before the market opens. A live...
iMobileApp's Custome
iMobileApp's Customer Base Continues to Diversify
March 24, 2015 08:30 ET | Sparta Commercial Services, Inc.
New York, March 24, 2015 (GLOBE NEWSWIRE) -- March 24, 2015.  Sparta Commercial Services, Inc. (OTCQB: SRCO), reported today that the customer base for its iMobileApp product continues to expand,...
Aldeyra Therapeutics Announces First Patient Enrolled in Sjogren-Larsson Syndrome Phase II Clinical Trial
March 24, 2015 08:30 ET | Aldeyra Therapeutics
LEXINGTON, Mass., March 24, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
GoTo.png
LogMeIn Brings Remote Support to Virtually Any Product With Rescue Lens
March 24, 2015 08:30 ET | GoTo Group, Inc.
BOSTON, March 24, 2015 (GLOBE NEWSWIRE) -- LogMeIn, Inc. (Nasdaq:LOGM) today introduced Rescue Lens, a new video-aided support capability aimed at addressing the rapidly expanding world of connected...
Risk Management: Changes in parameter values (7/15)
March 24, 2015 08:28 ET | Risk Management
NASDAQ OMX Derivatives Markets has decided to make changes to the Parameter Value List, see Appendix 13 in NASDAQ OMX Derivatives Markets Rules & Regulations. For further information...
Tenth Cohort Completed in Cellceutix Clinical Trial of Anti-Cancer Drug Kevetrin, No Adverse Events Reported
March 24, 2015 08:28 ET | Cellceutix
BEVERLY, MA--(Marketwired - Mar 24, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology,...
Nobia publicerar årsredovisningen för 2014
March 24, 2015 08:25 ET | Nobia AB
Nobias årsredovisning för 2014 finns nu tillgänglig på bolagets hemsida, www.nobia.se. En pdf-version av årsredovisningen finns även bifogad till detta pressmeddelande. Nobias årsredovisning för 2014...
Publication of Nobia’s annual report 2014
March 24, 2015 08:25 ET | Nobia AB
Nobia’s annual report for 2014 in Swedish is as of today available on the company’s Swedish website, www.nobia.se. Nobia’s annual report for 2014 includes a business description excluding...
22157.jpg
Automotive Axle & Propeller Shaft Market - Forecast and Analysis to 2019 for the $50+ Billion Industry
March 24, 2015 08:20 ET | Research and Markets
Dublin, March 24, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/qx87jj/automotive_axle) has announced the addition of the "Automotive Axle...